Skip to the page

Data / Medical devices / South Korea / Brightonix Imaging Inc.

Brightonix Imaging Inc.: FDA-registered device maker in Seoul, South Korea, 1 510(k) clearance

Brightonix Imaging Inc. is registered with the FDA (registration 3034246184) in Seoul, South Korea. It lists 1 device type. The FDA files 1 510(k) clearance under its listings, the newest dated August 15, 2025. Registered through 2026. FDA data exported November 2, 2026.

SpecStream is the live web data engine for teams and agents. It reads the FDA registration and listing, 510(k), PMA, recall and enforcement files from openFDA every week, and this page is that reading, joined by the FDA's own numbers. Ask for the makers of any device type in any country and new clearances, approvals and recalls arrive in your sheet, CRM, Slack or agent as the FDA publishes them.

FDA registration number
3034246184
Address
#B203, #409, Seongsu AK Valley 76, Yeonmujang-gil, Seongdong-gu, Seoul, South Korea, 04784
Owner or operator
Brightonix Imaging Inc. (10091856)
Roles
Complaint file establishment, Manufacturer
First device listed
August 20, 2025
Registered through
2026
Brand names listed
PHAROS

Devices it lists

DeviceProduct codeClassRoleSource
System, Tomography, Computed, EmissionKPS2Complaint file establishment, Manufactureraccessdata.fda.gov

510(k) clearances

The 510(k) numbers this establishment lists, with the FDA decision on each. The applicant is the company that holds the clearance.

Decided510(k) numberDeviceProduct codeDecisionApplicantSource
August 15, 2025K250170PHAROSKPSSubstantially EquivalentBrightonix Imagingaccessdata.fda.gov

Compare with other makers

Updated August 15, 2025. Read from openFDA bulk downloads (device registration and listing, 510(k), PMA, recall and enforcement files). CC0 1.0, public domain (openFDA terms of service). The files are joined on FDA identifiers: the 510(k) and PMA numbers a registration lists, and the recalling firm's FEI for recalls. Recall class comes from the FDA enforcement report. The FDA states that openFDA data is unvalidated and is not for decisions about medical care. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.